跳至主要内容
临床试验/NCT05204082
NCT05204082终止不适用

Use of SU-VEID™ As An Adjunct to Vein Visualization Technology to Improve Peripheral Venous Access Success in Children

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 169 人开始时间: 2022年3月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Mayo Clinic
入组人数
169
试验地点
1
主要终点
Percentage of Participants With IV Access at First Attempt

研究概览

简要总结

The purpose of this study is to determine if use of the SU-VEID™ in children facilitates an increase success rate of peripheral intravenous starts, in comparison to the conventional method of vein entry techniques.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patient age < 18 years old.
  • •Pediatric patients in surgical pre-op (0-18 years old), requiring an I.V. catheter for surgery who are difficult venous access.
  • •Written informed consent/ assent from the patient or legal guardian.

排除标准

  • •- Patient age > 18 years old.

研究组 & 干预措施

Standard IV Insertion

No Intervention

Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have standard IV insertion

SU-VEID assisted IV Insertion

Other

Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have IV insertion using SU-VEID device

干预措施: Single Use Vein Entry Indicator Device (Device)

结局指标

主要结局

Percentage of Participants With IV Access at First Attempt

时间窗: Baseline

Percentage of participants to have an IV access within the first attempt when using the SU-VEID Device in comparison to the conventional procedure

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael E. Nemergut

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验